SEC Form D · filed February 17, 2021
Cyteir Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Investment Advisor Pgim Limited · Newark, NJExec · DirectorZak Nugent · Cottonwood Heights, X1DirectorPaul S. Secrist · LEXINGTON, MAExecCarl Schoellhammer · Cambridge, MADirectorEnrico Scolari · San Diego, CADirectorMarkus Renschler · LEXINGTON, MAExec · DirectorKaren Hong · LEXINGTON, MADirectorPaul S. Secrist · LEXINGTON, MAExecSusan S. Molineaux · LEXINGTON, MADirectorAndrew S. Gengos · LEXINGTON, MAExecJohn R. Anderson · St. John's, Newfoundland and Labrador, CanadaDirectorBrian Hardecker · Long Island City, NYExec · DirectorRobert Langer · Cambridge, MADirectorAndrew Klaber · New York, NYDirectorFrank G. Haluska · Wayland, MADirectorSusan S. Molineaux · LEXINGTON, MADirectorJoseph S. Zakrzewski · LEXINGTON, MADirectorFraser R. Edison · St. John's, Newfoundland and Labrador, CanadaDirectorRacquel Bracken · LEXINGTON, MADirectorTimothy S. Romberger · LEXINGTON, MADirectorCarson R. Noel · St. John's, Newfoundland and Labrador, CanadaDirectorJanwillem Naesens · LEXINGTON, MADirectorMatthew Schutzman · Munster, INDirectorJean George · LEXINGTON, MADirectorAndrew S. Gengos · LEXINGTON, MAExecJoseph S. Zakrzewski · LEXINGTON, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗